Centers for Disease Control and Prevention (CDC) — 2021 Investments
8 investments dated 2021 · listed companies and verified rows first · show all
Seattle, US
Virginia Emery(Executive Officer, Director, Promoter)in
Co-investorsATEL VenturesE8 AngelsInnova Memphis, Inc.Cavallo VenturesLewis & Clark AgriFood
Charles River Analytics conducts research and develops AI-driven intelligent systems for defense, cybersecurity, space, and healthcare applications, serving the U.S.
AI & Machine LearningCybersecurityDefense TechRobotics
BiotechPortland, US
Lynnor Stevenson(Executive Officer, Director)Ann Bunnenberg(Executive Officer, Director)Tania Vu(Executive Officer, Director)Sandra Shotwell(Director)
Co-investorsElevate Capital
Antigen Discovery provides proteome microarray technology and research services for biomarker discovery, vaccine development, and therapeutic antibody identification.
BiotechDeep TechMedical DevicesIrvine, US
Xiaowu Liang(Co-founder, Chairman & CEO)Angela Yee(Co-founder, Board Member, COO & CFO)
PAI Life Sciences is a contract research organization specializing in developmental and translational research for vaccines, diagnostics, and therapeutics, with lab facilities for molecular, immunological, and chemical research.
BiotechHealthtechMedical DevicesSeattle, US
Darrick Carter(CEO)Gail Cassell(Distinguished Scientist)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


